A comparison of once daily and twice daily antihypertensive therapy with enalapril using noninvasive ambulatory BP monitoring

This publication has 6 references indexed in Scilit:

• Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril
  Clinical Pharmacology & Therapeutics, 1983
• Evaluation of a long-acting converting enzyme inhibitor (Enalapril) for the treatment of chronic congestive heart failure
  Journal of the American College of Cardiology, 1983
• Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.
  British Journal of Clinical Pharmacology, 1982
• Blood Pressure During Normal Daily Activities, Sleep, and Exercise
  JAMA, 1982
• ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".
  The Lancet, 1981
• Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.
  Circulation, 1978